One platform – from clinical and manufacturing through distribution and point of care – can provide a continuous product record that identifies risks and prescribes action before problems occur
SAN JOSE, Calif., Oct. 14, 2026 /PRNewswire-PRWeb/ -- ParkourSC today announced it has acquired Quartic, bringing together ParkourSC's clinical and commercial supply chain AI with Quartic's manufacturing AI to create a single, unified platform purpose-built for regulated life sciences and healthcare. For the first time, pharmaceutical, biotech, and contract manufacturing organizations will be able to follow a product across its entire lifecycle on a single platform with one continuous record drastically minimizing losses in quality, development time, product delivery, and planned therapies.
Combining the strengths and domain expertise of ParkourSC with Quartic moves the industry beyond reporting what went wrong. By connecting manufacturing data with clinical, distribution, and healthcare data, the unified AI platform can predict which batches, lots, and shipments are at risk and prescribe the best course of action, whether that is adjusting a process, rerouting a shipment, prioritizing inventory, or accelerating release. Deviation, verification, release, excursion, disposition, and regulatory documentation are all managed in one place, within pre-defined guardrails.
One Platform Across the Value Chain
With this combined platform, ParkourSC is the only company to bring all four critical areas of the life sciences value chain together on a single system and doubles ParkourSC's addressable market. Rather than stitching together point solutions, customers will now have a complete view of product quality for every function, from the plant floor to the distribution network
"In the past, life sciences companies never had a connected view of a product from its first batch to commercial distribution," said Mahesh Veerina, President and CEO of ParkourSC. "This changes today through our acquisition of Quartic, where we can finally close that gap with an end-to-end intelligence platform with proven GxP foundation that will serve as the definitive standard for autonomous regulated supply chains."
From Hindsight to Foresight
Currently, the record of how a batch was made lives in manufacturing systems. The record of what happens to it afterward lives in logistics and distribution systems. When an issue surfaces downstream, teams must rebuild the batch's history before they can act. That delay costs significant product, time, and confidence in supply. Combining the ParkourSC and Quartic platforms will allow customers to:
• Act on downstream risk with upstream evidence. The platform knows how each batch was made and how much stability margin it carried out of the plant. When an excursion or quality question arises, disposition starts from that evidence, not a new investigation. Batches released near the edge of specification can be protected before a disruption occurs.
• Carry critical quality evidence across the product lifecycle. Knowledge of the attributes that affect patient safety and efficacy, and the root causes behind their variation, moves forward from clinical manufacturing into commercial manufacturing and distribution. It is no longer rebuilt at each handoff.
• Move from clinical to commercial manufacturing faster. Process understanding built in clinical batches informs scale-up and technology transfer, shortening the path to commercial supply.
"The most important facts about a batch are established when it is made, but they are needed long after it leaves the plant," said Rajiv Anand, CEO and Co-Founder of Quartic. "Connecting manufacturing and supply chain data puts the full history of the product in front of the people making release, disposition, and scale-up decisions and ensures the quality of the product that ultimately gets delivered to patients."
Both companies are purpose-built for regulated life sciences and already share customers. Documented outcomes include fit-for-use disposition decisions cut from three days to one minute, and 15 to 20 percent higher batch yield in biologics manufacturing. The platform sits above the MES, LIMS, QMS, historian, and logistics systems customers already run, so neither customers nor their partners need to replace them.
"By not having one complete view of a product across the entire value chain, the life sciences industry has paid a steep price in lost product, wasted time, and delayed therapies," said Michael Marks, Founding Managing Partner at Celesta Capital and ParkourSC Board Director. "This is a problem I know well having spent years running complex global supply chains. With ParkourSC's acquisition of Quartic, pharmaceutical and biotech companies can now follow a product across its entire lifecycle and act on problems before they reach the patient. This move positions ParkourSC at the forefront of the industry's move toward AI-driven, autonomous supply chains."
About ParkourSC
ParkourSC is the vertical AI platform for life sciences and healthcare supply chains, purpose-built for regulated networks where a wrong decision costs product, compliance, and patient safety. Founded in clinical trial supply, ParkourSC now spans manufacturing, commercial distribution, and healthcare. The platform prevents quality exceptions before they occur and prescribes the right response. For the exceptions that remain, it closes the loop from detection and stability budget assessment through disposition and the evidence record, within defined guardrails. ParkourSC sits above the systems customers already run and maintains one continuous product quality record, from batch to point of care. ParkourSC, based in San Jose, California, serves pharmaceutical, biotech, and contract manufacturing organizations, distributors, and health systems worldwide. Learn more at parkoursc.com.
About Quartic
Quartic provides a decision intelligence platform for manufacturing operations management in regulated batch manufacturing. Its industrial DataOps platform, combined with industrial AI, helps customers achieve consistent quality, optimized throughput, and higher asset utilization. Built for GxP environments, Quartic's AI applications are used by leading biomanufacturers for deviation monitoring and investigations, Continuous Process Verification, and Expedited Batch Release. Quartic is now a ParkourSC company.
Media Contact
Kimberley Kasper, ParkourSC, 1 6507046255, [email protected], https://www.parkoursc.com/
SOURCE ParkourSC
Share this article